# FDA Inspection 1004195 - Bayer AG - January 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/bayer-ag/c65a5db9-942c-4b9b-a5cf-90ff21e2bf78
Source feed: FDA_Inspections

> FDA Inspection 1004195 for Bayer AG on January 20, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1004195
- Company Name: Bayer AG
- Inspection Date: 2017-01-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1247034 - 2023-09-07](https://www.keypedia.com/records/fda_inspections/bayer-ag/745504cb-756f-4fe2-a8a1-01c5a1c51700)
- [FDA Inspection 1209999 - 2022-05-13](https://www.keypedia.com/records/fda_inspections/bayer-ag/4c012418-6530-43d6-abd3-60cd3c2d8860)
- [FDA Inspection 1125538 - 2020-07-27](https://www.keypedia.com/records/fda_inspections/bayer-ag/6cdbe19f-b1e4-4367-a031-b71895e387b6)
- [FDA Inspection 1084360 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/bayer-ag/b9423cc2-a943-45c0-ba8c-4a9adfb46666)
- [FDA Inspection 975815 - 2016-06-03](https://www.keypedia.com/records/fda_inspections/bayer-ag/ff4d59c1-cab1-4da4-9598-1a49e165c137)

Company: https://www.keypedia.com/companies/bayer-ag/c999165f-4c13-4f49-b979-087064975cb0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c